Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Tranexamic Acid for Blood Loss in Caesarean Section for Placenta Praevia
NCT04350645Unknown
- Sponsor
- Hospital Canselor Tuanku Muhriz
- Start
- Mar 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of tranexamic acid in placenta previa (2 arms), sponsored by Hospital Canselor Tuanku Muhriz. Primary endpoints: Amount of blood loss during Caesarean section at 24 hours and Changes of haemoglobin at 24 hours. Status: unknown.
02
Drugs
tranexamic acid
03
Conditions
placenta previa
Beyond the preview
Go deeper on NCT04350645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04350645.